NCT00650052View on ClinicalTrials.gov

Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

Zonisamide Capsules 100 mg

100mg, single dose fasting

DRUG

Zonegran® Capsules 100 mg

100mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY